Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Type I diabetes mellitus | R-HSA-5683209 | map04940 | dizocilpine | 3351 | drug-path |
SNARE interactions in vesicular transport | R-HSA-428625 | map04130 | dizocilpine | 3351 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | dizocilpine | 3351 | drug-path |
Pathways in cancer | R-HSA-9824443 | map05200 | dizocilpine | 3351 | drug-path |
Shigellosis | 0 | map05131 | dizocilpine | 3351 | drug-path |
T cell receptor signaling pathway | R-HSA-983705 | map04660 | dizocilpine | 3351 | drug-path |
Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | dizocilpine | 3351 | drug-path |
Cell cycle | R-HSA-1640170 | map04110 | dizocilpine | 3351 | drug-path |
Bladder cancer | R-HSA-9700206 | map05219 | dizocilpine | 3351 | drug-path |
Small cell lung cancer | R-HSA-5619066 | map05222 | dizocilpine | 3351 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | mianserin | 4184 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | mianserin | 4184 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | mianserin | 4184 | drug-path |
Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | mianserin | 4184 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | mianserin | 4184 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | mianserin | 4184 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | mianserin | 4184 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | fluticasone | 5311101 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | fluticasone | 5311101 | drug-path |
Basal transcription factors | R-HSA-3232118 | map03022 | fluticasone | 5311101 | drug-path |